BHCM
SWAV

Brevan Howard Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Brevan Howard Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,189
Closed -$417K – 1415
2023
Q4 		$417K Buy
+2,189
New +$414K 0.01% 566
2023
Q3 		– Sell
-886
Closed -$253K – 455
2023
Q2 		$253K Buy
+886
New +$246K 0.01% 169

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Brevan Howard Capital Management's SWAV Position: Q1 2024 in Review

Brevan Howard Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 2,189 shares — an estimated $417K sold.

Brevan Howard Capital Management first reported a position in SWAV in Q2 2023 and held it in 2 quarters. The position peaked at $417K in Q4 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Brevan Howard Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 2,189 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $417K.
  • Brevan Howard Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Brevan Howard Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $417K in Q4 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Brevan Howard Capital Management's 13F filing for Q1 2024, filed 15 May 2024.